Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome - Clinical prognostic factors and risk for disease progression

被引:506
作者
Kim, YH
Liu, HL
Mraz-Gernhard, S
Varghese, A
Hoppe, RT
机构
[1] Stanford Univ, Sch Med, Dept Dermatol, Multidisciplinary Cytaneous Lymophoma Clin, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA
关键词
D O I
10.1001/archderm.139.7.857
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objectives: To study and update the clinical characteristics and long-term outcome of our patients with mycosis fungoides (MF) and Sezary syndrome (SS), and to identify important clinical factors predictive of survival and disease progression. Design: A single-center, retrospective cohort analysis. Setting: Academic referral center for cutaneous lymphoma. Patients: Five hundred twenty-five patients with MF and SS evaluated and managed at Stanford University Cutaneous Lymphoma Clinic, Stanford, Calif, from 1958 through 1999. Main Outcome Measures: We calculated long-term actuarial overall and disease-specific survivals and disease progression by the Kaplan-Meier method, and relative risk (RR) for survival calculated from expected survivals in control populations. Results: The majority of our patients presented with T1 (30%) or T2 (37%) disease; 18% presented with T3 and 15% with T4 skin involvement. Forty-three percent of deaths were attributable to MF, primarily in patients with T3 or T4 disease. The patients with a more advanced T classification and clinical stage had a worse survival outcome. Except for patients with T1 or stage IA disease, the RR for death is greater in patients with MF than in a control population (RR, 2.2 in stage IB/IIA disease, 3.9 in stage IIB/III disease, and 12.8 in stage IV disease). Despite similar overall survival in patients with stage IB or IIA disease, their disease-specific survivals were significantly different (P = .006). The most significant clinical prognostic factors in the univariate analysis were patient age, TNM and B classifications, overall clinical stage groupings, and the presence or absence of extracutaneous disease. In the multivariate analysis, patient age, T classification, and the presence of extracutaneous disease were the most important independent factors. The risk for disease progression to a more advanced TNM or B classification, worse clinical stage, or death due to MF correlated with the severity of the initial T classification. The risk for development of extracutaneous disease also correlated with T classifications none of these patients had T1 disease when their extracutaneous disease was detected. Conclusions: Patients with MF and SS have varying risks for disease progression or death. The most important clinical predictive factors for survival include patient age, T classification, and the presence of extracutaneous disease. The significant disease-specific survival differences between different clinical stages validate the usefulness of the present MF clinical staging system of the National Cancer institute.
引用
收藏
页码:857 / 866
页数:10
相关论文
共 36 条
[1]   Prognostic factors in Sezary syndrome: A multivariate analysis of clinical, haematological and immunological features [J].
Bernengo, MG ;
Quaglino, P ;
Novelli, M ;
Cappello, N ;
Doveil, GC ;
Lisa, E ;
De Matteis, A ;
Fierro, MT ;
Appino, A .
ANNALS OF ONCOLOGY, 1998, 9 (08) :857-863
[2]  
BUNN PA, 1979, CANCER TREAT REP, V63, P725
[3]  
Cox D., 1989, Analysis of Binary Data
[4]  
COX DR, 1972, J R STAT SOC B, V34, P187
[5]   Mycosis fungoides in young patients: Clinical characteristics and outcome [J].
Crowley, JJ ;
Nikko, A ;
Varghese, A ;
Hoppe, RT ;
Kim, YH .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 38 (05) :696-701
[6]   Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides [J].
de Coninck, EC ;
Kim, YH ;
Varghese, A ;
Hoppe, RT .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (03) :779-784
[7]   Prognostic factor analysis in mycosis fungoides/Sezary syndrome [J].
Diamandidou, E ;
Colome, M ;
Fayad, L ;
Duvic, M ;
Kurzrock, R .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 40 (06) :914-924
[8]   Transformation of mycosis fungoides/Sezary syndrome: Clinical characteristics and prognosis [J].
Diamandidou, E ;
Colome-Grimmer, M ;
Fayad, L ;
Duvic, M ;
Kurzrock, R .
BLOOD, 1998, 92 (04) :1150-1159
[9]   Detection of a peripheral blood T cell clone is an independent prognostic marker in mycosis fungoides [J].
Fraser-Andrews, EA ;
Woolford, AJ ;
Russell-Jones, R ;
Seed, PT ;
Whittaker, SJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 114 (01) :117-121
[10]   A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES [J].
GEHAN, EA .
BIOMETRIKA, 1965, 52 :203-+